Affiliation:
1. Departments of Pharmacology
2. Maxillofacial and Plastic Surgery, Graduate School of Dentistry, Tohoku University, 4-1 Seiryo-Machi, Aoba-Ku, Sendai 980-8575
3. Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Minato-Ku, Tokyo 108-8639, Japan
Abstract
ABSTRACT
Within a few hours of its injection into mice, lipopolysaccharide (LPS) induces hypoglycemia and the production of various cytokines. We previously found that interleukin-1α (IL-1α), IL-1β, and tumor necrosis factor alpha (TNF-α) induce hypoglycemia and that the minimum effective dose of IL-1α or IL-1β is about 1/1,000 that of TNF-α. In the present study, we examined the contribution made by IL-1 to the hypoglycemic action of LPS. Nine other cytokines tested were all inactive at inducing hypoglycemia. LPS produced hypoglycemia in mice deficient in either IL-1α or IL-1β but not in mice deficient in both cytokines (IL-1α and -1β knockout [IL-1α/β KO] mice). IL-1α, IL-1β, and TNF-α induced hypoglycemia in IL-1α/β KO mice, as they did in normal control mice. The LPS-induced elevation of serum cortisol was weaker in IL-1α/β KO mice than in control mice, and, in the latter, serum cortisol was markedly raised while blood glucose was declining. IL-1α decreased blood glucose both in NOD mice (which have impaired insulin production) and in KK-Ay mice (insulin resistant). These results suggest that (i) cortisol may not be involved in mediating the resistance of IL-1α/β KO mice to the hypoglycemic action of LPS, (ii) as a mediator, IL-1 is a prerequisite for the hypoglycemic action of LPS, (iii) IL-1α and IL-1β perform mutual compensation, and (iv) IL-1 plays a role as the primary stimulator of the many anabolic reactions required for the elaboration of immune responses against infection.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference56 articles.
1. Alheim, K., Z. Chai, G. Fantuzzi, H. Hasanvan, D. Malinowsky, E. Di Santo, P. Ghezzi, and C. A. Dinarello. 1997. Hyperresponsive febrile reactions to interleukin (IL)-1α and IL-1β, and altered brain cytokine mRNA and serum cytokine levels, in IL-1β-deficient mice. Proc. Natl. Acad. Sci. USA94:2681-2686.
2. Andonova, M., D. Goundasheva, P. Georgiev, and V. Ivanov. 1998. Effects of indomethacin on lipopolysaccharide-induced plasma PGE2 concentrations and clinical pathological disorders in experimental endotoxemia. Vet. Hum. Toxicol.40:14-18.
3. Antal-Szálmas, P. 2000. Evaluation of CD14 in host defence. Eur. J. Clin. Investig.30:167-179.
4. Berk, J. L., J. F. Hagen, W. H. Beyer, and M. J. Gerber. 1970. Hypoglycemia of shock. Ann. Surg.171:400-408.
5. Besedovsky, H. O., and A. del Rey. 1989. Interleukin-1 and glucose homeostasis: an example of the biological relevance of immune-neuroendocrine interactions. Horm. Res.31:94-99.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献